‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy - United Kingdom
doi 10.1586/14737140.2014.971112
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2014
Authors
Publisher
Informa UK Limited